back to top
BusinessGlenmark to sell 75% in life sciences arm to Nirma for Rs...

Glenmark to sell 75% in life sciences arm to Nirma for Rs 5,651.5 cr


Glenmark Pharmaceuticals on Thursday said it will sell a 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,651.5 crore.

The company's board at its meeting held on September 21, 2023, considered and approved the sale of 91,895,379 shares representing 75 per cent share capital of Glenmark Life Sciences Ltd to Nirma Ltd at a price of Rs 615 per share, aggregating to Rs 5,651.5 crore, the Mumbai-based drug maker said in a regulatory filing.

As part of the transaction, the company, Glenmark Life Sciences and Nirma have agreed to certain non-compete and non-solicit arrangements for a specified period, it added.

The Northlines is an independent source on the Web for news, facts and figures relating to Jammu, Kashmir and Ladakh and its neighbourhood.

Share post:


More like this

India spice exports dip 20% in May after safety scares at top brands

Spice exports dip amid pesticide concerns for top brands India's...

Hyundai seeks up to $3 billion in potentially India’s largest IPO

Potentially India's Largest Ever IPO Hyundai Motor India is seeking...

Survey reveals nearly half of urban Indians affected by financial fraud in recent years

Nearly Half of Urban Population Victims of Financial Crimes,...

Wholesale inflation in India rises to highest level in 15 months at 2.61% in May

Inflation at wholesale level touches 15-month high in May The...